|
1
|
Braun MM, Overbeek-Wager EA and Grumbo RJ:
Diagnosis and management of endometrial cancer. Am Fam Physician.
93:468–474. 2016.PubMed/NCBI
|
|
2
|
Prat J, Gallardo A, Cuatrecasas M and
Catasús L: Endometrial carcinoma: Pathology and genetics.
Pathology. 39:72–87. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Uharcek P: Prognostic factors in
endometrial carcinoma. J Obstet Gynaecol Res. 34:776–783. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rossouw JE, Anderson GL, Prentice RL,
LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA,
Howard BV, Johnson KC, et al: Writing Group for the Women's Health
Initiative Investigators: Risks and benefits of estrogen plus
progestin in healthy postmenopausal women: Principal results From
the Women's Health Initiative randomized controlled trial. JAMA.
288:321–333. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Corrado G, Baiocco E, Carosi M and Vizza
E: Progression of conservatively treated endometrial complex
atypical hyperplasia in a young woman: A case report. Fertil
Steril. 90:2006.e5–2006.e8. 2008. View Article : Google Scholar
|
|
6
|
Ofinran O and Balega J: The value of
magnetic resonance imaging in investigating complex atypical
hyperplasia of the endometrium. Minerva Ginecol. 68:400–404.
2016.PubMed/NCBI
|
|
7
|
Jurcevic S, Olsson B and Klinga-Levan K:
MicroRNA expression in human endometrial adenocarcinoma. Cancer
Cell Int. 14:882014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang S, Jia Y, Liu X, Winters C, Wang X,
Zhang Y, Devor EJ, Hovey AM, Reyes HD, Xiao X, et al: Systematic
dissection of the mechanisms underlying progesterone receptor
downregulation in endometrial cancer. Oncotarget. 5:9783–9797.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Torres A, Torres K, Wdowiak P, Paszkowski
T and Maciejewski R: Selection and validation of endogenous
controls for microRNA expression studies in endometrioid
endometrial cancer tissues. Gynecol Oncol. 130:588–594. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Santulli G: MicroRNAs and endothelial
(Dys) function. J Cell Physiol. 231:1638–1644. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang C, Chen X, Alattar M, Wei J and Liu
H: MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis
of gastric cancer. Cancer Gene Ther. 22:291–301. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Widodo Djati MS and Rifa'i M: Role of
MicroRNAs in carcinogenesis that potential for biomarker of
endometrial cancer. Ann Med Surg. 7:9–13. 2016. View Article : Google Scholar
|
|
13
|
Boren T, Xiong Y, Hakam A, Wenham R, Apte
S, Wei Z, Kamath S, Chen DT, Dressman H and Lancaster JM: MicroRNAs
and their target messenger RNAs associated with endometrial
carcinogenesis. Gynecol Oncol. 110:206–215. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu YY, Wu HJ, Ma HD, Xu LP, Huo Y and Yin
LR: MicroRNA-503 suppresses proliferation and cell-cycle
progression of endometrioid endometrial cancer by negatively
regulating cyclin D1. FEBS J. 280:3768–3779. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kalia M: Biomarkers for personalized
oncology: Recent advances and future challenges. Metabolism. 64
Suppl 1:S16–S21. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee TS, Jeon HW, Kim YB, Kim YA, Kim MA
and Kang SB: Aberrant microRNA expression in endometrial carcinoma
using formalin-fixed paraffin-embedded (FFPE) tissues. PLoS One.
8:e814212013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Luna-Aguirre CM, de la Luz Martinez-Fierro
M, Mar-Aguilar F, Garza-Veloz I, Treviño-Alvarado V, Rojas-Martinez
A, Jaime-Perez JC, Malagon-Santiago GI, Gutierrez-Aguirre CH,
Gonzalez-Llano O, et al: Circulating microRNA expression profile in
B-cell acute lymphoblastic leukemia. Cancer Biomark. 15:299–310.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pellatt DF, Stevens JR, Wolff RK, Mullany
LE, Herrick JS and Samowitz W: Slattery ml: Expression profiles of
miRNA subsets distinguish human colorectal carcinoma and normal
colonic mucosa. Clin Transl Gastroenterol. 7:e1522016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Plieskatt JL, Rinaldi G, Feng Y, Levine
PH, Easley S, Martinez E, Hashmi S, Sadeghi N, Brindley PJ, Bethony
JM, et al: Methods and matrices: Approaches to identifying miRNAs
for nasopharyngeal carcinoma. J Transl Med. 12:32014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Özata DM, Caramuta S, Velázquez-Fernández
D, Akçakaya P, Xie H, Höög A, Zedenius J, Bäckdahl M, Larsson C and
Lui WO: The role of microRNA deregulation in the pathogenesis of
adrenocortical carcinoma. Endocr Relat Cancer. 18:643–655. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rucker JJ and McGuffin P: Chipping away at
major depressive disorder. Genome Biol. 15:4212014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lopez JP, Lim R, Cruceanu C, Crapper L,
Fasano C, Labonte B, Maussion G, Yang JP, Yerko V, Vigneault E, et
al: miR-1202 is a primate-specific and brain-enriched microRNA
involved in major depression and antidepressant treatment. Nat Med.
20:764–768. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Z, Zhang H, Zhang P, Li J, Shan Z and
Teng W: Upregulation of miR-2861 and miR-451 expression in
papillary thyroid carcinoma with lymph node metastasis. Med Oncol.
30:5772013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen ZF, Ma LL and Xue HB: Common
polymorphisms of the microRNA genes (miR-146a and miR-196a-2) and
gastric cancer risk: An updated meta-analysis. Genet Mol Res.
14:8589–8601. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Y, Jin L, Chen D, Liu J, Su Z, Yang S,
Gui Y, Mao X, Nie G and Lai Y: Tumor suppressive miR-196a is
associated with cellular migration, proliferation and apoptosis in
renal cell carcinoma. Mol Med Rep. 14:560–566. 2016.PubMed/NCBI
|
|
26
|
Liu P, Xin F and Ma CF: Clinical
significance of serum miR-196a in cervical intraepithelial
neoplasia and cervical cancer. Genet Mol Res. 14:17995–18002. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fan Y, Fan J, Huang L, Ye M, Huang Z, Wang
Y, Li Q and Huang J: Increased expression of microRNA-196a predicts
poor prognosis in human ovarian carcinoma. Int J Clin Exp Pathol.
8:4132–4137. 2015.PubMed/NCBI
|
|
28
|
Xiong H, Li Q, Liu S, Wang F, Xiong Z,
Chen J, Chen H, Yang Y, Tan X, Luo Q, et al: Integrated microRNA
and mRNA transcriptome sequencing reveals the potential roles of
miRNAs in stage I endometrioid endometrial carcinoma. PLoS One.
9:e1101632014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Darda L, Hakami F, Morgan R, Murdoch C,
Lambert DW and Hunter KD: The role of HOXB9 and miR-196a in head
and neck squamous cell carcinoma. PLoS One. 10:e01222852015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Roisman A, Huamán Garaicoa F, Metrebian F,
Narbaitz M, Kohan D, García Rivello H, Fernandez I, Pavlovsky A,
Pavlovsky M, Hernández L, et al: SOXC and MiR17-92 gene expression
profiling defines two subgroups with different clinical outcome in
mantle cell lymphoma. Genes Chromosomes Cancer. 55:531–540. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu C, Wang S, Zhu S, Wang H, Gu J, Gui Z,
Jing J, Hou X and Shao Y: MAP3K1-targeting therapeutic artificial
miRNA suppresses the growth and invasion of breast cancer in vivo
and in vitro. Springerplus. 5:112016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang X, Yao X, Qin C, Luo P and Zhang J:
Investigation of the molecular mechanisms underlying metastasis in
prostate cancer by gene expression profiling. Exp Ther Med.
12:925–932. 2016.PubMed/NCBI
|
|
33
|
Zhu M, Xu Z, Wang K, Wang N and Li Y:
microRNA and gene networks in human pancreatic cancer. Oncol Lett.
6:1133–1139. 2013.PubMed/NCBI
|
